These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25078358)

  • 1. High yield purification of Plasmodium falciparum merozoites for use in opsonizing antibody assays.
    Hill DL; Eriksson EM; Schofield L
    J Vis Exp; 2014 Jul; (89):. PubMed ID: 25078358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites.
    Hill DL; Eriksson EM; Carmagnac AB; Wilson DW; Cowman AF; Hansen DS; Schofield L
    PLoS One; 2012; 7(12):e51692. PubMed ID: 23300556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity.
    Hill DL; Wilson DW; Sampaio NG; Eriksson EM; Ryg-Cornejo V; Harrison GLA; Uboldi AD; Robinson LJ; Beeson JG; Siba P; Cowman AF; Hansen DS; Mueller I; Schofield L
    Infect Immun; 2016 Aug; 84(8):2175-2184. PubMed ID: 27185785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.
    Osier FH; Feng G; Boyle MJ; Langer C; Zhou J; Richards JS; McCallum FJ; Reiling L; Jaworowski A; Anders RF; Marsh K; Beeson JG
    BMC Med; 2014 Jul; 12():108. PubMed ID: 24980799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
    Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Plasmodium falciparum merozoites with the protease inhibitor E64 and mechanical filtration increases their susceptibility to complement activation.
    Stoute JA; Landmesser ME; Biryukov S
    PLoS One; 2020; 15(8):e0237786. PubMed ID: 32822376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breadth of Functional Antibodies Is Associated With Plasmodium falciparum Merozoite Phagocytosis and Protection Against Febrile Malaria.
    Kana IH; Singh SK; Garcia-Senosiain A; Dodoo D; Singh S; Adu B; Theisen M
    J Infect Dis; 2019 Jun; 220(2):275-284. PubMed ID: 30820557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple, ex vivo phagocytosis assay of Plasmodium vivax merozoites by flow cytometry.
    Farias E; Bezerra F; Baia-da-Silva DC; Chaves YO; Cardoza TB; de Almeida MEM; Oliveira LB; Lalwani P; Orlandi PP; Lacerda MVG; Lopes SCP; Nogueira PA
    Mem Inst Oswaldo Cruz; 2019; 114():e190158. PubMed ID: 31596312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
    Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
    Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay.
    Quintana MDP; Anabire NG; Hviid L
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure.
    Yman V; White MT; Asghar M; Sundling C; Sondén K; Draper SJ; Osier FHA; Färnert A
    BMC Med; 2019 Jan; 17(1):22. PubMed ID: 30696449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with merozoite surface protein 2 fused to a Plasmodium-specific carrier protein elicits strain-specific and strain-transcending, opsonizing antibody.
    Eacret JS; Gonzales DM; Franks RG; Burns JM
    Sci Rep; 2019 Jun; 9(1):9022. PubMed ID: 31227760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targets of complement-fixing antibodies in protective immunity against malaria in children.
    Reiling L; Boyle MJ; White MT; Wilson DW; Feng G; Weaver R; Opi DH; Persson KEM; Richards JS; Siba PM; Fowkes FJI; Takashima E; Tsuboi T; Mueller I; Beeson JG
    Nat Commun; 2019 Feb; 10(1):610. PubMed ID: 30723225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.
    Chan JA; Stanisic DI; Duffy MF; Robinson LJ; Lin E; Kazura JW; King CL; Siba PM; Fowkes FJ; Mueller I; Beeson JG
    Eur J Immunol; 2017 Dec; 47(12):2124-2136. PubMed ID: 28833064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
    Rono J; Osier FH; Olsson D; Montgomery S; Mhoja L; Rooth I; Marsh K; Färnert A
    Clin Infect Dis; 2013 Nov; 57(10):1409-16. PubMed ID: 23983244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytophilic Antibodies Against Key Plasmodium falciparum Blood Stage Antigens Contribute to Protection Against Clinical Malaria in a High Transmission Region of Eastern India.
    Kana IH; Garcia-Senosiain A; Singh SK; Tiendrebeogo RW; Chourasia BK; Malhotra P; Sharma SK; Das MK; Singh S; Adu B; Theisen M
    J Infect Dis; 2018 Aug; 218(6):956-965. PubMed ID: 29733355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria.
    Hill DL; Eriksson EM; Li Wai Suen CS; Chiu CY; Ryg-Cornejo V; Robinson LJ; Siba PM; Mueller I; Hansen DS; Schofield L
    PLoS One; 2013; 8(9):e74627. PubMed ID: 24040299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Robust Phagocytosis Assay to Evaluate the Opsonic Activity of Antibodies against Plasmodium falciparum-Infected Erythrocytes.
    Teo A; Hasang W; Boeuf P; Rogerson S
    Methods Mol Biol; 2015; 1325():145-52. PubMed ID: 26450386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.